Miller TP - Search Results

1

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease.

Miller TP, Chase EM, Dorr R, Dalton WS, Lam KS, Salmon SE. Miller TP, et al. Anticancer Drugs. 1998 Feb;9(2):135-40. doi: 10.1097/00001813-199802000-00004. Anticancer Drugs. 1998. PMID: 9510499 Clinical Trial.

2

The phenomenon of multidrug resistance in non-Hodgkin's lymphoma.

Miller TP, Chase EM, Dalton WS, Grogan TM. Miller TP, et al. Cancer Treat Res. 1996;85:107-17. doi: 10.1007/978-1-4615-4129-5_8. Cancer Treat Res. 1996. PMID: 9043778 Review. No abstract available.

3

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E, Fisher RI. Miller TP, et al. N Engl J Med. 1998 Jul 2;339(1):21-6. doi: 10.1056/NEJM199807023390104. N Engl J Med. 1998. PMID: 9647875 Free article. Clinical Trial.

4

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE. Miller TP, et al. J Clin Oncol. 1991 Jan;9(1):17-24. doi: 10.1200/JCO.1991.9.1.17. J Clin Oncol. 1991. PMID: 1670642

5

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

Pennock GD, Dalton WS, Roeske WR, Appleton CP, Mosley K, Plezia P, Miller TP, Salmon SE. Pennock GD, et al. Among authors: miller tp. J Natl Cancer Inst. 1991 Jan 16;83(2):105-10. doi: 10.1093/jnci/83.2.105. J Natl Cancer Inst. 1991. PMID: 1988684

6

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE. Dalton WS, et al. Among authors: miller tp. J Clin Oncol. 1989 Apr;7(4):415-24. doi: 10.1200/JCO.1989.7.4.415. J Clin Oncol. 1989. PMID: 2564428

7

Mood alterations in patients treated with chlorambucil.

Hehn ST, Dorr RT, Miller TP. Hehn ST, et al. Among authors: miller tp. Clin Lymphoma. 2003 Dec;4(3):179-82. doi: 10.3816/clm.2003.n.028. Clin Lymphoma. 2003. PMID: 14715101

8

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.

Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS. Salmon SE, et al. J Natl Cancer Inst. 1989 May 3;81(9):696-701. doi: 10.1093/jnci/81.9.696. J Natl Cancer Inst. 1989. PMID: 2565403

9

Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial.

Taylor CW, LeBlanc M, Fisher RI, Moore DF Sr, Roach RW, Elias L, Miller TP. Taylor CW, et al. Among authors: miller tp. Anticancer Drugs. 2000 Oct;11(9):695-700. doi: 10.1097/00001813-200010000-00004. Anticancer Drugs. 2000. PMID: 11129730 Clinical Trial.

10

Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.

Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP. Salmon SE, et al. Among authors: miller tp. Blood. 1991 Jul 1;78(1):44-50. Blood. 1991. PMID: 1676918 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters